Ambulatory Arrhythmia Monitoring Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Ambulatory Arrhythmia Monitoring Devices Market
The global ambulatory arrhythmia monitoring devices market size was valued at USD 4.59 billion in 2020 and is projected to grow from USD 5.19 billion in 2021 to USD 8.01 billion by 2028, exhibiting a CAGR of 6.4% during the forecast period of 2021-2028.
The pandemic affected the supply chain and behind-schedule methods. Still, augmented demand for ambulatory arrhythmia tracking gadgets gave rise to the increasing need for remote tracking and telehealth solutions as a hindrance to the ambulatory arrhythmia monitoring devices market growth.
The global demands in cardiovascular sicknesses, thriving awareness concerning early detection, innovations in wearable technology, and the implementation of off-distant tracking solutions are driving the growth of the ambulatory arrhythmia tracking devices market.
Advanced wearable gadgets are transforming the panorama of ambulatory arrhythmia monitoring. Smartwatches and fitness trackers can continuously monitor heart fees, supplying real-time information on cardiac hobbies and expanding the ambulatory arrhythmia monitoring devices market share globally. Improved sensor generation and advanced algorithms decorate the accuracy of these gadgets, enabling early detection of capability arrhythmias and other cardiac abnormalities.
Comprehensive Analysis of Ambulatory Arrhythmia Monitoring Devices Market
The Ambulatory Arrhythmia Monitoring Devices Market is segmented into numerous vital classes. By tool type, Holter monitors held the most significant marketplace percentage in 2020 due to their cost-effectiveness and favorable reimbursement regulations, while cellular cardiac telemetry is predicted to develop at the best fee because of actual-time monitoring benefits. By type, outside monitors led the marketplace due to their non-invasive nature and lower costs. In contrast, implantable monitors are expected to see mild increases because of advancements in tracking over a lengthy period. By utility, atrial fibrillation ruled the marketplace because of its rising prevalence, with ventricular fibrillation anticipated to develop notably due to improved awareness by giving up-user, diagnostic centers, and clinics led the market in 2020, driven through superior tracking gadgets and professional specialists, with hospitals and ASCs protecting a large proportion because of multispecialty care services.
The North America region led the ambulatory arrhythmia monitoring devices market by benefitting a size of USD 2.10 billion in 2020 due to the vast demand for car and movie & coating packages within the packaging enterprise.
The leading players in the ambulatory arrhythmia monitoring devices market significantly influence its growth trajectory and set industry standards. These key players, including Abbott (Lake Bluff, U.S.), Medtronic (Dublin, Ireland), Boston Scientific Corporation (Marlborough, U.S.), BioTelemetry (Malvern, U.S.), iRhythm Technologies, Inc. (San Francisco, U.S.), Medi-Lynx Cardiac Monitoring, LLC. (Plano, U.S.), CamNtech Ltd (Fenstanton, U.K.), and ZOLL Medical Corporation (Chelmsford, U.S.), contribute to a competitive landscape, driving innovation, advancing technology, and expanding the market.
In June 2019, ZOLL Medical Corporation delivered the µCor coronary heart failure and arrhythmia management gadget, designed to reveal heart rhythm abnormalities and assist in the early detection of heart failure decompensation.
Segmentation Table
ATTRIBUTE DETAILS
Study Period2017-2028
Base Year2020
Estimated Year2021
Forecast Period2021-2028
Historical Period2017-2019
UnitValue (USD billion)
SegmentationDevice Type, Type, Application, End-user, and Region
By Device typeHolter Monitors
Event Monitors
Mobile Cardiac Telemetry Monitors
By TypeExternal
Implantable
By ApplicationTachycardia
Bradycardia
Atrial Fibrillation
Ventricular Fibrillation
Others
By End-userHospitals and ASCs
Diagnostics Centers and Clinics
Others
By GeographyNorth America (By Device Type, By Type, By Application, By End-user, and By Country)
U.S. (By Application)
Canada (By Application)
Europe (By Device Type, By Type, By Application, By End-user, and By Country)
U.K. (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific (By Device Type, By Type, By Application, By End-user, and By Country)
Japan (By Application)
China (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Device Type, By Type, By Application, By End-user, and By Country)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
Middle East & Africa (By Device Type, By Type, By Application, By End-user, and By Country)
South Africa (By Application)
GCC (By Application)
Rest of Middle East & Africa (By Application)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Number of Key Cardiovascular Disorders, By Region/Country, 2020
- 4.2. New Product Launches, By Key Players
- 4.3. Impact of COVID-19 on the Market
- 4.4. Recent Key Developments, Mergers, and Acquisitions, Key Players
- 5. Global Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2017-2028
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Device Type
- 5.2.1. Holter Monitors
- 5.2.2. Event Monitors
- 5.2.3. Mobile Cardiac Telemetry Monitors
- 5.3. Market Analysis, Insights and Forecast – By Type
- 5.3.1. External
- 5.3.2. Implantable
- 5.4. Market Analysis, Insights and Forecast – By Application
- 5.4.1. Tachycardia
- 5.4.2. Bradycardia
- 5.4.3. Atrial Fibrillation
- 5.4.4. Ventricular Fibrillation
- 5.4.5. Others
- 5.5. Market Analysis, Insights and Forecast – By End User
- 5.5.1. Hospitals and ASCs
- 5.5.2. Diagnostics Centers and Clinics
- 5.5.3. Others
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
- 6. North America Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2017-2028
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Device Type
- 6.2.1. Holter Monitors
- 6.2.2. Event Monitors
- 6.2.3. Mobile Cardiac Telemetry Monitors
- 6.3. Market Analysis, Insights and Forecast – By Type
- 6.3.1. External
- 6.3.2. Implantable
- 6.4. Market Analysis, Insights and Forecast – By Application
- 6.4.1. Tachycardia
- 6.4.2. Bradycardia
- 6.4.3. Atrial Fibrillation
- 6.4.4. Ventricular Fibrillation
- 6.4.5. Others
- 6.5. Market Analysis, Insights and Forecast – By End User
- 6.5.1. Hospitals and ASCs
- 6.5.2. Diagnostics Centers and Clinics
- 6.5.3. Others
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.1.1. By Application
- 6.6.2. Canada
- 6.6.2.1. By Application
- 7. Europe Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2017-2028
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Device Type
- 7.2.1. Holter Monitors
- 7.2.2. Event Monitors
- 7.2.3. Mobile Cardiac Telemetry Monitors
- 7.3. Market Analysis, Insights and Forecast – By Type
- 7.3.1. External
- 7.3.2. Implantable
- 7.4. Market Analysis, Insights and Forecast – By Application
- 7.4.1. Tachycardia
- 7.4.2. Bradycardia
- 7.4.3. Atrial Fibrillation
- 7.4.4. Ventricular Fibrillation
- 7.4.5. Others
- 7.5. Market Analysis, Insights and Forecast – By End User
- 7.5.1. Hospitals and ASCs
- 7.5.2. Diagnostics Centers and Clinics
- 7.5.3. Others
- 7.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 7.6.1. U.K
- 7.6.1.1. By Application
- 7.6.2. Germany
- 7.6.2.1. By Application
- 7.6.3. France
- 7.6.3.1. By Application
- 7.6.4. Spain
- 7.6.4.1. By Application
- 7.6.5. Italy
- 7.6.5.1. By Application
- 7.6.6. Scandinavia
- 7.6.6.1. By Application
- 7.6.7. Rest of Europe
- 7.6.7.1. By Application
- 8. Asia Pacific Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2017-2028
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Device Type
- 8.2.1. Holter Monitors
- 8.2.2. Event Monitors
- 8.2.3. Mobile Cardiac Telemetry Monitors
- 8.3. Market Analysis, Insights and Forecast – By Type
- 8.3.1. External
- 8.3.2. Implantable
- 8.4. Market Analysis, Insights and Forecast – By Application
- 8.4.1. Tachycardia
- 8.4.2. Bradycardia
- 8.4.3. Atrial Fibrillation
- 8.4.4. Ventricular Fibrillation
- 8.4.5. Others
- 8.5. Market Analysis, Insights and Forecast – By End User
- 8.5.1. Hospitals and ASCs
- 8.5.2. Diagnostics Centers and Clinics
- 8.5.3. Others
- 8.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.6.1. Japan
- 8.6.1.1. By Application
- 8.6.2. China
- 8.6.2.1. By Application
- 8.6.3. India
- 8.6.3.1. By Application
- 8.6.4. Australia
- 8.6.4.1. By Application
- 8.6.5. Southeast Asia
- 8.6.5.1. By Application
- 8.6.6. Rest of Asia Pacific
- 8.6.6.1. By Application
- 9. Latin America Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2017-2028
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Device Type
- 9.2.1. Holter Monitors
- 9.2.2. Event Monitors
- 9.2.3. Mobile Cardiac Telemetry Monitors
- 9.3. Market Analysis, Insights and Forecast – By Type
- 9.3.1. External
- 9.3.2. Implantable
- 9.4. Market Analysis, Insights and Forecast – By Application
- 9.4.1. Tachycardia
- 9.4.2. Bradycardia
- 9.4.3. Atrial Fibrillation
- 9.4.4. Ventricular Fibrillation
- 9.4.5. Others
- 9.5. Market Analysis, Insights and Forecast – By End User
- 9.5.1. Hospitals and ASCs
- 9.5.2. Diagnostics Centers and Clinics
- 9.5.3. Others
- 9.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.6.1. Brazil
- 9.6.1.1. By Application
- 9.6.2. Mexico
- 9.6.2.1. By Application
- 9.6.3. Rest of Latin America
- 9.6.3.1. By Application
- 10. Middle East & Africa Ambulatory Arrhythmia Monitoring Devices Market Analysis, Insights and Forecast, 2017-2028
- 10.1. Market Analysis, Insights and Forecast – By Device Type
- 10.1.1. Holter Monitors
- 10.1.2. Event Monitors
- 10.1.3. Mobile Cardiac Telemetry Monitors
- 10.2. Market Analysis, Insights and Forecast – By Type
- 10.2.1. External
- 10.2.2. Implantable
- 10.3. Market Analysis, Insights and Forecast – By Application
- 10.3.1. Tachycardia
- 10.3.2. Bradycardia
- 10.3.3. Atrial Fibrillation
- 10.3.4. Ventricular Fibrillation
- 10.3.5. Others
- 10.4. Market Analysis, Insights and Forecast – By End User
- 10.4.1. Hospitals and ASCs
- 10.4.2. Diagnostics Centers and Clinics
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.5.1. GCC
- 10.5.1.1. By Application
- 10.5.2. South Africa
- 10.5.2.1. By Application
- 10.5.3. Rest of Middle East & Africa
- 10.5.3.1. By Application
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2020)
- 11.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
- 11.3.1. Abbott
- 11.3.1.1. Overview,
- 11.3.1.2. Products,
- 11.3.1.3. SWOT Analysis,
- 11.3.1.4. Recent Developments,
- 11.3.1.5. Strategies,
- 11.3.1.6. financials (Based on Availability)
- 11.3.2. Medtronic
- 11.3.2.1. Overview,
- 11.3.2.2. Products,
- 11.3.2.3. SWOT Analysis,
- 11.3.2.4. Recent Developments,
- 11.3.2.5. Strategies,
- 11.3.2.6. financials (Based on Availability)
- 11.3.3. Boston Scientific Corporation
- 11.3.3.1. Overview,
- 11.3.3.2. Products,
- 11.3.3.3. SWOT Analysis,
- 11.3.3.4. Recent Developments,
- 11.3.3.5. Strategies,
- 11.3.3.6. financials (Based on Availability)
- 11.3.4. BioTelemetry
- 11.3.4.1. Overview,
- 11.3.4.2. Products,
- 11.3.4.3. SWOT Analysis,
- 11.3.4.4. Recent Developments,
- 11.3.4.5. Strategies,
- 11.3.4.6. financials (Based on Availability)
- 11.3.5. iRhythm Technologies, Inc.
- 11.3.5.1. Overview,
- 11.3.5.2. Products,
- 11.3.5.3. SWOT Analysis,
- 11.3.5.4. Recent Developments,
- 11.3.5.5. Strategies,
- 11.3.5.6. financials (Based on Availability)
- 11.3.6. Medi-Lynx Cardiac Monitoring, LLC.
- 11.3.6.1. Overview,
- 11.3.6.2. Products,
- 11.3.6.3. SWOT Analysis,
- 11.3.6.4. Recent Developments,
- 11.3.6.5. Strategies,
- 11.3.6.6. financials (Based on Availability)
- 11.3.7. CamNtech Ltd
- 11.3.7.1. Overview,
- 11.3.7.2. Products,
- 11.3.7.3. SWOT Analysis,
- 11.3.7.4. Recent Developments,
- 11.3.7.5. Strategies,
- 11.3.7.6. financials (Based on Availability)
- 11.3.8. ZOLL Medical Corporation
- 11.3.8.1. Overview,
- 11.3.8.2. Products,
- 11.3.8.3. SWOT Analysis,
- 11.3.8.4. Recent Developments,
- 11.3.8.5. Strategies,
- 11.3.8.6. financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook